By Professor Sallie Pearson

Journal articles

Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H, 2020, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, 29, pp. 365 - 373, http://dx.doi.org/10.1136/bmjqs-2019-009897

Mathieson S; Wertheimer G; Maher CG; Christine Lin CW; McLachlan AJ; Buchbinder R; Pearson SA; Underwood M, 2020, 'What proportion of patients with chronic noncancer pain are prescribed an opioid medicine? Systematic review and meta-regression of observational studies', Journal of Internal Medicine, 287, pp. 458 - 474, http://dx.doi.org/10.1111/joim.13026

Peng Z; Hayen A; Kirk MD; Pearson S; Cheng AC; Liu B, 2020, 'Microbiology testing associated with antibiotic dispensing in older community-dwelling adults', BMC Infectious Diseases, 20, http://dx.doi.org/10.1186/s12879-020-05029-z

Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA, 2020, 'Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine', Medical Journal of Australia, 212, pp. 321 - 327, http://dx.doi.org/10.5694/mja2.50552

Raichand S; Pearson SA; Zoega H; Buckley NA; Havard A, 2020, 'Utilisation of teratogenic medicines before and during pregnancy in Australian women', Australian and New Zealand Journal of Obstetrics and Gynaecology, 60, pp. 218 - 224, http://dx.doi.org/10.1111/ajo.13044

Chiu T; Brett J; Pearson S; Schaffer A, 2020, 'Patterns of pregabalin initiation and discontinuation after its subsidy in Australia', British Journal of Clinical Pharmacology, 86, pp. 1882 - 1887, http://dx.doi.org/10.1111/bcp.14276

Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA, 2020, 'Codeine use and harms in Australia: evaluating the effects of re-scheduling', Addiction, 115, pp. 451 - 459, http://dx.doi.org/10.1111/add.14798

Luckett T; Newton-John T; Phillips J; Holliday S; Giannitrapani K; Powell-Davies G; Lovell M; Liauw W; Rowett D; Pearson SA; Raymond B; Heneka N; Lorenz K, 2020, 'Risk of opioid misuse in people with cancer and pain and related clinical considerations: A qualitative study of the perspectives of Australian general practitioners', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2019-034363

De Oliveira Costa J; Schaffer AL; Medland NA; Litchfield M; Narayan SW; Guy R; McManus H; Pearson SA, 2020, 'Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study', AIDS Patient Care and STDs, 34, pp. 81 - 91, http://dx.doi.org/10.1089/apc.2019.0278

Daniels B; Tervonen HE; Pearson SA, 2020, 'Identifying incident cancer cases in dispensing claims: A validation study using Australia's Repatriation Pharmaceutical Benefits Scheme (PBS) data', International Journal of Population Data Science, 5, http://dx.doi.org/10.23889/ijpds.v5i1.1152

Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; Leeuwen MTV; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM; van Leeuwen M, 2020, 'Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)', PLoS ONE, 15, pp. e0230373, http://dx.doi.org/10.1371/journal.pone.0230373

Daniels B; Pearson SA; Buckley NA; Bruno C; Zoega H, 2020, 'Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016', Therapeutic Advances in Gastroenterology, 13, http://dx.doi.org/10.1177/1756284820913743

Darshni A; Farshid A; MacIsaac A; Hsu B; Pearson S; Falster M; Hyun K; D'Silva M; Brieger D, 2020, '730 Exploration of Single Antiplatelet Drug use in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Cardiac Stenting', Heart, Lung and Circulation, 29, pp. S364 - S365, http://dx.doi.org/10.1016/j.hlc.2020.09.737

Coleman L; Brett J; Daniels B; Pearson S; Falster M, 2020, 'Medicine reviews: do they reduce benzodiazepine use in older Australians?', Public Health Research & Practice, 31, http://dx.doi.org/10.17061/phrp30452015

Pearson SA; Buckley N; Stamatakis E, 2019, 'Exercise trials for blood pressure control: Keeping it REAL', British Journal of Sports Medicine, 53, pp. 1443 - 1444, http://dx.doi.org/10.1136/bjsports-2019-100787

Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N, 2019, 'Prescription opioid dispensing in Australian children and adolescents: a national population-based study', The Lancet Child and Adolescent Health, 3, pp. 881 - 888, http://dx.doi.org/10.1016/S2352-4642(19)30329-3

Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, 121, pp. 904 - 911, http://dx.doi.org/10.1038/s41416-019-0612-5

Reekie J; Donovan B; Guy R; Hocking JS; Kaldor JM; Mak D; Preen D; Ward J; Liu B; Wand H; Pearson S, 2019, 'Risk of Ectopic Pregnancy and Tubal Infertility Following Gonorrhea and Chlamydia Infections', Clinical Infectious Diseases, 69, pp. 1621 - 1623, http://dx.doi.org/10.1093/cid/ciz145

Feng Y; Flitcroft K; van Leeuwen MT; Elshaug AG; Spillane A; Pearson SA, 2019, 'Patterns of immediate breast reconstruction in New South Wales, Australia: a population-based study', ANZ Journal of Surgery, 89, pp. 1230 - 1235, http://dx.doi.org/10.1111/ans.15381

Schaffer AL; Buckley NA; Cairns R; Pearson S, 2019, 'Comparison of Prescribing Patterns before and after Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia', JAMA Network Open, 2, pp. e1911590, http://dx.doi.org/10.1001/jamanetworkopen.2019.11590

Daniels B; Kiely BE; Tang M; Tervonen H; Pearson SA, 2019, 'Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015)', BMC Cancer, 19, pp. 909, http://dx.doi.org/10.1186/s12885-019-6126-y

Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 61, pp. 1 - 7, http://dx.doi.org/10.1016/j.canep.2019.05.001

Peacock A; Chiu V; Leung J; Dobbins T; Larney S; Gisev N; Pearson SA; Degenhardt L, 2019, 'Protocol for the Data-Linkage Alcohol Cohort Study (DACS): Investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2019-030605

Chen Y; Kirk MD; Stuart R; Cheng AC; Pearson SA; Hayen A; Banks E; Liu B, 2019, 'Socio-demographic and health service factors associated with antibiotic dispensing in older Australian adults', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0221480

Page AT; Falster MO; Litchfield M; Pearson SA; Etherton-Beer C, 2019, 'Polypharmacy among older Australians, 2006–2017: a population-based study', Medical Journal of Australia, 211, pp. 71 - 75, http://dx.doi.org/10.5694/mja2.50244

Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 60, pp. 156 - 161, http://dx.doi.org/10.1016/j.canep.2019.04.004

Tang M; Schaffer A; Pearson SA, 2019, 'Embracing the full spectrum of real-world data for cancer medicines research in Australia', Asia-Pacific Journal of Clinical Oncology, 15, pp. 186 - 187, http://dx.doi.org/10.1111/ajco.13121

Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA, 2019, 'Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients', Pharmacoepidemiology and Drug Safety, 28, pp. 812 - 820, http://dx.doi.org/10.1002/pds.4751

Badgery-Parker T; Feng Y; Pearson SA; Levesque JF; Dunn S; Elshaug AG, 2019, 'Exploring variation in low-value care: A multilevel modelling study', BMC Health Services Research, 19, http://dx.doi.org/10.1186/s12913-019-4159-1

Schaffer AL; Zoega H; Tran DT; Buckley NA; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics', Australian & New Zealand Journal of Psychiatry, 53, pp. 000486741984776 - 000486741984776, http://dx.doi.org/10.1177/0004867419847764

Costa JDO; Pearson SA; Acurcio FDA; Bonolo PDF; Silveira MR; Ceccato MDGB, 2019, 'Health-related quality of life among HIV-infected patients initiating treatment in Brazil in the single-tablet regimen era', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 31, pp. 572 - 581, http://dx.doi.org/10.1080/09540121.2019.1576841

Han D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL, 2019, 'Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate', Pharmacoepidemiology and Drug Safety, 28, pp. 521 - 527, http://dx.doi.org/10.1002/pds.4755

Badgery-Parker T; Pearson SA; Dunn S; Elshaug AG, 2019, 'Measuring Hospital-Acquired Complications Associated with Low-Value Care', JAMA Internal Medicine, 179, pp. 499 - 505, http://dx.doi.org/10.1001/jamainternmed.2018.7464

Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L, 2019, 'A population-based study of transdermal fentanyl initiation in Australian clinical practice', European Journal of Clinical Pharmacology, 75, pp. 401 - 408, http://dx.doi.org/10.1007/s00228-018-2588-0

Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations', Addiction, 114, pp. 404 - 405, http://dx.doi.org/10.1111/add.14556

Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA, 2019, 'Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)—in reply', Addiction, 114, pp. 572 - 573, http://dx.doi.org/10.1111/add.14531

Peacock A; Larance B; Bruno R; Pearson SA; Buckley NA; Farrell M; Degenhardt L, 2019, 'Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting', Addiction, 114, pp. 389 - 399, http://dx.doi.org/10.1111/add.14380

Badgery-Parker T; Pearson SA; Scott IA; Elshaug AG, 2019, 'Response to: A 'Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia' by Morton and Thompson', BMJ Quality and Safety, 28, pp. 255 - 256, http://dx.doi.org/10.1136/bmjqs-2018-009213

Lord SJ; Kiely BE; Pearson SA; Daniels B; O'Connell DL; Beith J; Bulsara MK; Houssami N, 2019, 'Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: A population-based health record linkage study protocol', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-026414

Du W; Gnjidic D; Pearson SA; Hilmer SN; McLachlan AJ; Blyth F; Viney R; Joshy G; Day C; Banks E, 2019, 'Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: A prospective cohort investigation among adults aged 45 years and over in Australia', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-027305

Cairns R; Karanges EA; Wong A; Brown JA; Robinson J; Pearson SA; Dawson AH; Buckley NA, 2019, 'Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: A population-based retrospective cohort study in Australia', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2018-026001

Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H, 2019, 'Anticholinergic medicines use among older adults before and after initiating dementia medicines', British Journal of Clinical Pharmacology, 85, pp. 1957 - 1963, http://dx.doi.org/10.1111/bcp.13976

Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A, 2019, 'Evidence-practice gaps in postdischarge initiation with oral anticoagulants in patients with atrial fibrillation', Journal of the American Heart Association, 8, pp. e014287, http://dx.doi.org/10.1161/JAHA.119.014287

Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA, 2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, 28, pp. 97 - 105, http://dx.doi.org/10.1002/pds.4683

Chalmers K; Badgery-Parker T; Pearson SA; Brett J; Scott I; Elshaug AG, 2019, 'Measuring 21 low-value health care procedures in Australian private health insurance claims data (2010 – 2014)', BMJ

Campbell G; Lintzeris N; Gisev N; Larance B; Pearson S; Degenhardt L, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, 210, http://dx.doi.org/10.5694/mja2.12047

Brett J; Zoega H; Buckley NA; Daniels BJ; Elshaug AG; Pearson SA, 2018, 'Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia', BMC Health Services Research, 18, pp. 1009, http://dx.doi.org/10.1186/s12913-018-3811-5

Morgan A; Joshy G; Schaffer A; Laba T-L; Litchfield M; Pearson S; Banks E, 2018, 'Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants', PLoS ONE, 13, pp. e0208824, http://dx.doi.org/10.1371/journal.pone.0208824

Gisev N; Pearson SA; Dobbins T; Currow DC; Blyth F; Larney S; Dunlop A; Mattick RP; Wilson A; Degenhardt L, 2018, 'Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2018-025840

Gisev N; Campbell G; Lalic S; Larney S; Peacock A; Nielsen S; Pearson SA; Degenhardt L, 2018, 'Current Opioid Access, Use, and Problems in Australasian Jurisdictions', Current Addiction Reports, 5, pp. 464 - 472, http://dx.doi.org/10.1007/s40429-018-0227-6

Back to profile page